CRGY Stock Analysis: Crescent Energy | NYSE
Oil & Gas E&P | NYSE, USA | Market Cap: 5.268m USD | 12M Return: 54.1% | US44952J1043 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 79.4M
EPS Trend: -83.2%
Qual. Beats: 0
Rev. Trend: 98.5%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 4.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Crescent Energy Company (NYSE: CRGY) is a U.S.-based independent exploration and production (E&P) company that develops crude oil, natural gas, and natural gas liquids. Its upstream operations are concentrated in three major hydrocarbon-producing basins: the Eagle Ford (South Texas), the Permian (West Texas/New Mexico), and the Uinta (Utah). In addition to operated and non-operated working interests in these regions, the company also holds a portfolio of minerals and royalty interests, which provide it with non-operated, cost-free exposure to drilling activity across U.S. basins. Founded in 2011 and headquartered in Houston, Texas, Crescent Energy went public in December 2021 and is classified within the GICS Energy sector under the Oil & Gas Exploration & Production sub-industry.
The E&P business model involves identifying, acquiring, and developing hydrocarbon reserves, with revenue typically tied directly to realized commodity prices for oil, natural gas, and NGLs. A diversified basin footprint like Crescents can help reduce geologic and operational concentration risk, while minerals and royalty interests generally offer higher-margin, lower-capital exposure compared to traditional drilling operations, since royalty owners do not bear well costs.
- WTI crude oil price swings drive Permian production margins
- Acquisitive consolidation expands Uinta Basin and minerals acreage
- Free cash flow funds debt reduction and shareholder returns
| Net Income: 54.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 14.67 > 1.0 |
| NWC/Revenue: -1.50% < 20% (prev -2.83%; Δ 1.33% < -1%) |
| CFO/TA 0.16 > 3% & CFO 1.96b > Net Income 54.8m |
| Net Debt (5.13b) to EBITDA (1.44b): 3.56 < 3 |
| Current Ratio: 0.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (381.8m) vs 12m ago 48.24% < -2% |
| Gross Margin: 75.26% > 18% (prev 82.77%; Δ -7.52% > 0.5%) |
| Asset Turnover: 39.42% > 50% (prev 35.19%; Δ 4.23% > 0%) |
| Interest Coverage Ratio: 0.40 > 6 (EBIT TTM 141.3m / Interest Expense TTM 354.4m) |
| A: -0.01 (Total Current Assets 1.10b - Total Current Liabilities 1.17b) / Total Assets 12.0b |
| B: 0.00 (Retained Earnings 33.3m / Total Assets 12.0b) |
| C: 0.01 (EBIT TTM 141.3m / Avg Total Assets 10.9b) |
| D: 0.75 (Book Value of Equity 5.16b / Total Liabilities 6.85b) |
| Altman-Z'' = 0.85 = B |
| DSRI: 0.90 (Receivables 668.8m/596.3m, Revenue 4.31b/3.47b) |
| GMI: 1.10 (GM 82.77% / 75.26%) |
| AQI: -26.50 (AQ_t -0.33 / AQ_t-1 0.01) |
| SGI: 1.24 (Revenue 4.31b / 3.47b) |
| TATA: -0.16 (NI 54.8m - CFO 1.96b) / TA 12.0b) |
| Beneish M = -19.16 (Cap -4..+1) = AAA |
As of October 08, 2026, the stock is trading at USD 13.47 with a total of 4,313,895 shares traded. Over the past week, the price has changed by +4.50%, over one month by -5.07%, over three months by +44.57% and over the past year by +54.07%.
Current recommended Stop Loss: 12.40 (which is 7.9% or 2.3 ATR below the current price).
Crescent Energy has received a consensus analysts rating of 4.29. Therefore, it is recommended to buy CRGY.
- StrongBuy: 11
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 17.5 | 29.7% |
P/E Trailing = 167.375
P/E Forward = 6.3452
P/S = 1.0266
P/B = 0.8344
Revenue TTM = 4.31b USD
EBIT TTM = 141.3m USD
EBITDA TTM = 1.44b USD
Long Term Debt = 5.17b USD (from longTermDebt, last quarter)
Short Term Debt = 111.2m USD (from shortTermDebt, last quarter)
Debt = 5.39b USD (from shortLongTermDebtTotal, last quarter) + Leases 112.6m
Net Debt = 5.13b USD (calculated: Debt 5.39b - CCE 264.9m)
Enterprise Value = 10.4b USD (5.27b + Debt 5.39b - CCE 264.9m)
Interest Coverage Ratio = 0.40 (Ebit TTM 141.3m / Interest Expense TTM 354.4m)
EV/FCF = 11.56x (Enterprise Value 10.4b / FCF TTM 899.2m)
FCF Yield = 8.65% (FCF TTM 899.2m / Enterprise Value 10.4b)
FCF Margin = 20.87% (FCF TTM 899.2m / Revenue TTM 4.31b)
Net Margin = 1.27% (Net Income TTM 54.8m / Revenue TTM 4.31b)
Gross Margin = 75.26% ((Revenue TTM 4.31b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 93.23% (prev 91.37%)
Tobins Q-Ratio = 0.87 (Enterprise Value 10.4b / Total Assets 12.0b)
Interest Expense / Debt = 6.57% (Interest Expense 354.4m / Debt 5.39b)
Taxrate = 25.60% (169.9m / 663.6m)
NOPAT = 105.1m (EBIT 141.3m * (1 - 25.60%))
Current Ratio = 0.94 (Total Current Assets 1.10b / Total Current Liabilities 1.17b)
Debt / Equity = 1.04 (Debt 5.39b / totalStockholderEquity, last quarter 5.16b)
Debt / EBITDA = 3.56 (Net Debt 5.13b / EBITDA 1.44b)
Debt / FCF = 5.70 (Net Debt 5.13b / FCF TTM 899.2m)
Total Stockholder Equity = 4.87b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.50% (Net Income 54.8m / Total Assets 12.0b)
RoE = 1.12% (Net Income TTM 54.8m / Total Stockholder Equity 4.87b)
RoCE = 1.41% (EBIT 141.3m / Capital Employed (Equity 4.87b + L.T.Debt 5.17b))
RoIC = 0.98% (NOPAT 105.1m / Invested Capital 10.7b)
WACC = 6.97% (E(5.27b)/V(10.7b) * Re(9.09%) + D(5.39b)/V(10.7b) * Rd(6.57%) * (1-Tc(0.26)))
Discount Rate = 9.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 96.34 | Cagr: 39.98%
[DCF] Terminal Value 75.44% ; FCFF base≈899.2m ; Y1≈902.9m ; Y5≈956.5m
[DCF] Fair Price = 29.51 (EV 14.9b - Net Debt 5.13b = Equity 9.75b / Shares 330.4m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: -83.20 | EPS CAGR: -19.32% | SUE: 0.77 | # QB: 0
Revenue Correlation: 98.46 | Revenue CAGR: 24.56% | SUE: 4.0 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.61 | Chg30d=+9.64% | Revisions=+0% | Analysts=13
EPS current Year (2026-12-31): EPS=2.51 | Chg30d=+8.85% | Revisions=+58% | GrowthEPS=+39.6% | GrowthRev=+39.6%
EPS next Year (2027-12-31): EPS=2.38 | Chg30d=+9.35% | Revisions=+73% | GrowthEPS=-5.1% | GrowthRev=-6.6%
[Analyst] Revisions Ratio: +62% (up=18, down=3)